These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25630910)

  • 1. Reactive oxygen metabolites are closely associated with the diagnosis and prognosis of coronary artery disease.
    Hirata Y; Yamamoto E; Tokitsu T; Kusaka H; Fujisue K; Kurokawa H; Sugamura K; Maeda H; Tsujita K; Kaikita K; Hokimoto S; Sugiyama S; Ogawa H
    J Am Heart Assoc; 2015 Jan; 4(2):. PubMed ID: 25630910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Pivotal Role of a Novel Biomarker of Reactive Oxygen Species in Chronic Kidney Disease.
    Hirata Y; Yamamoto E; Tokitsu T; Fujisue K; Kurokawa H; Sugamura K; Sakamoto K; Tsujita K; Tanaka T; Kaikita K; Hokimoto S; Sugiyama S; Ogawa H
    Medicine (Baltimore); 2015 Jun; 94(25):e1040. PubMed ID: 26107676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of circulating leukocyte subtype counts in patients with coronary artery disease.
    Yamamoto E; Sugiyama S; Hirata Y; Tokitsu T; Tabata N; Fujisue K; Sugamura K; Sakamoto K; Tsujita K; Matsumura T; Kaikita K; Hokimoto S
    Atherosclerosis; 2016 Dec; 255():210-216. PubMed ID: 27612676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Reactive Oxidative Metabolites Among New Categories of Nonischemic Heart Failure.
    Nishihara T; Yamamoto E; Sueta D; Fujisue K; Usuku H; Oike F; Takae M; Tabata N; Ito M; Yamanaga K; Kanazawa H; Arima Y; Araki S; Takashio S; Nakamura T; Suzuki S; Sakamoto K; Izumiya Y; Kaikita K; Tsujita K
    J Am Heart Assoc; 2021 Apr; 10(7):e016765. PubMed ID: 33733816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of reactive oxidative metabolites in patients with heart failure with reduced left ventricular ejection fraction.
    Nishihara T; Tokitsu T; Sueta D; Oike F; Takae M; Fujisue K; Usuku H; Ito M; Kanazawa H; Araki S; Arima Y; Takashio S; Nakamura T; Sakamoto K; Suzuki S; Kaikita K; Yamamoto E; Tsujita K
    J Card Fail; 2021 Jan; 27(1):57-66. PubMed ID: 32791184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of Circulating Decoy Receptor 3 in Predicting Coronary Artery Disease Severity and Future Major Adverse Cardiovascular Events in Patients With Multivessel Coronary Artery Disease.
    Chang TY; Hsu CY; Huang PH; Chiang CH; Leu HB; Huang CC; Chen JW; Lin SJ
    Am J Cardiol; 2015 Oct; 116(7):1028-33. PubMed ID: 26254707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-term prognostic value of CT angiography and exercise ECG in patients with suspected CAD.
    Pontone G; Andreini D; Bartorelli AL; Bertella E; Cortinovis S; Mushtaq S; Foti C; Annoni A; Formenti A; Baggiano A; Conte E; Bovis F; Veglia F; Ballerini G; Fiorentini C; Agostoni P; Pepi M
    JACC Cardiovasc Imaging; 2013 Jun; 6(6):641-50. PubMed ID: 23764093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcoronary Concentration Gradient of microRNA-133a and Outcome in Patients With Coronary Artery Disease.
    De Rosa R; De Rosa S; Leistner D; Boeckel JN; Keller T; Fichtlscherer S; Dimmeler S; Zeiher AM
    Am J Cardiol; 2017 Jul; 120(1):15-24. PubMed ID: 28511772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of CT angiography in patients with inconclusive functional stress tests.
    de Azevedo CF; Hadlich MS; Bezerra SG; Petriz JL; Alves RR; de Souza O; Rati M; Albuquerque DC; Moll J
    JACC Cardiovasc Imaging; 2011 Jul; 4(7):740-51. PubMed ID: 21757164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of carotid plaque neovascularization at contrast-enhanced US to predict coronary events in patients with coronary artery disease.
    Zhu Y; Deng YB; Liu YN; Bi XJ; Sun J; Tang QY; Deng Q
    Radiology; 2013 Jul; 268(1):54-60. PubMed ID: 23440321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary severity score and C-reactive protein predict major adverse cardiovascular events in patients with stable coronary artery disease (from the Taichung CAD study).
    Pan HC; Sheu WH; Lee WJ; Lee WL; Liao YC; Wang KY; Lee IT; Wang JS; Liang KW
    Clin Chim Acta; 2015 May; 445():93-100. PubMed ID: 25818243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac computed tomographic angiography in an outpatient setting: an analysis of clinical outcomes over a 40-month period.
    Gopal A; Nasir K; Ahmadi N; Gul K; Tiano J; Flores M; Young E; Witteman AM; Holland TC; Flores F; Mao SS; Budoff MJ
    J Cardiovasc Comput Tomogr; 2009; 3(2):90-5. PubMed ID: 19269915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Monocyte-to-Lymphocyte Ratio on Heart Failure Characteristics and Hospitalizations in a Coronary Angiography Cohort.
    Gijsberts CM; Ellenbroek GHJM; Ten Berg MJ; Huisman A; van Solinge WW; Lam CS; Asselbergs FW; den Ruijter HM; Pasterkamp G; Hoefer IE; de Kleijn DP
    Am J Cardiol; 2017 Sep; 120(6):911-916. PubMed ID: 28779870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification and prognostic implication of plasma biomarkers in nondiabetic patients with stable coronary artery disease: the role of high-sensitivity C-reactive protein.
    Leu HB; Lin CP; Lin WT; Wu TC; Chen JW
    Chest; 2004 Oct; 126(4):1032-9. PubMed ID: 15486359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echolucent carotid plaques predict future coronary events in patients with coronary artery disease.
    Honda O; Sugiyama S; Kugiyama K; Fukushima H; Nakamura S; Koide S; Kojima S; Hirai N; Kawano H; Soejima H; Sakamoto T; Yoshimura M; Ogawa H
    J Am Coll Cardiol; 2004 Apr; 43(7):1177-84. PubMed ID: 15063426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term prognostic value of IgM antibodies against phosphorylcholine for adverse cardiovascular events in patients with stable coronary heart disease.
    Imhof A; Koenig W; Jaensch A; Mons U; Brenner H; Rothenbacher D
    Atherosclerosis; 2015 Dec; 243(2):414-20. PubMed ID: 26520895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of coronary artery calcium score for risk stratification in patients with non significant perfusion defects by myocardial perfusion single photon emission computed tomography.
    Barros MV; Nunes Mdo C; Braga G; Rabelo DR; Magalhães K; Scaramello F; Siqueira MH
    Cardiol J; 2015; 22(3):330-5. PubMed ID: 25428736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial.
    Harutyunyan M; Gøtze JP; Winkel P; Johansen JS; Hansen JF; Jensen GB; Hilden J; Kjøller E; Kolmos HJ; Gluud C; Kastrup J
    Immunobiology; 2013 Jul; 218(7):945-51. PubMed ID: 23294528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease.
    Ramchand J; Patel SK; Srivastava PM; Farouque O; Burrell LM
    PLoS One; 2018; 13(6):e0198144. PubMed ID: 29897923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of elevated lipoprotein(a) in coronary artery revascularization patients.
    Kwon SW; Lee BK; Hong BK; Kim JY; Choi EY; Sung JM; Rhee JH; Park YM; Ma DW; Chung H; Mun HS; Lee SJ; Park JK; Min PK; Yoon YW; Rim SJ; Kwon HM
    Int J Cardiol; 2013 Sep; 167(5):1990-4. PubMed ID: 22633779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.